Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents

by Anita Sainsbury, Alexander C. Ford
Published 2011-03-01

Pharmacotherapy for Irritable Bowel Syndrome

by Michael Camilleri, Alexander C. Ford
Published 2017-10-01

Insights into the evaluation and management of dyspepsia: recent developments and new guidelines

by Christopher J. Black, Lesley A. Houghton, Alexander C. Ford
Published 2018-10-01

Fatigue and its associated factors in microscopic colitis

by John S. Kane, Andrew J. Irvine, Yannick Derwa, Alexander C. Ford
Published 2018-09-01

High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment

by John S. Kane, Andrew J. Irvine, Yannick Derwa, Olorunda Rotimi, Alexander C. Ford
Published 2018-06-01

Ipilimumab-induced colitis: experience from a tertiary referral center

by Anthony O’Connor, Maria Marples, Clive Mulatero, John Hamlin, Alexander C. Ford
Published 2016-07-01

The Effect of Antidepressants on the Course of Inflammatory Bowel Disease

by Barry J. Hall, P. John Hamlin, David J. Gracie, Alexander C. Ford
Published 2018-01-01

Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases

by Laura Tasson, Fabiana Zingone, Brigida Barberio, Romina Valentini, Pamela Ballotta, Alexander C. Ford, Marco Scarpa, Imerio Angriman, Matteo Fassan, Edoardo Savarino
Published 2021-07-01

Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease

by Anthony O’Connor, Raguprakash Ratnakumaran, Lisa Warren, Debbie Pullen, Anna Errington, David J. Gracie, Rebecca C. Sagar, P. John Hamlin, Alexander C. Ford
Published 2019-03-01

Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin

by Yannick Derwa, Christopher J.M. Williams, Ruchit Sood, Saqib Mumtaz, M. Hassan Bholah, Christian P. Selinger, P. John Hamlin, Alexander C. Ford, David J. Gracie
Published 2018-01-01

Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results

by Rebecca Sagar, Marco V. Lenti, Tanya Clark, Helen J. Rafferty, David J. Gracie, Alexander C. Ford, Anthony O’Connor, Tariq Ahmad, P. John Hamlin, Christian P. Selinger
Published 2021-04-01

Acupuncture and related therapies for treating irritable bowel syndrome: overview of systematic reviews and network meta-analysis

by Irene X. Y. Wu, Charlene H. L. Wong, Robin S. T. Ho, William K. W. Cheung, Alexander C. Ford, Justin C. Y. Wu, Arthur D. P. Mak, Holger Cramer, Vincent C. H. Chung
Published 2019-01-01

Acupuncture and related therapies for treating irritable bowel syndrome: overview of systematic reviews and network meta-analysis

by Irene X.Y. Wu, Charlene H.L. Wong, Robin S.T. Ho, William K.W. Cheung, Alexander C. Ford, Justin C.Y. Wu, Arthur D.P. Mak, Holger Cramer, Eun Hae Ha, Vincent C.H. Chung
Published 2020-01-01

Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites

by Parisa Hosseinzadeh, Paris R. Watson, Timothy W. Craven, Xinting Li, Stephen Rettie, Fátima Pardo-Avila, Asim K. Bera, Vikram Khipple Mulligan, Peilong Lu, Alexander S. Ford, Brian D. Weitzner, Lance J. Stewart, Adam P. Moyer, Maddalena Di Piazza, Joshua G. Whalen, Per Jr. Greisen, David W. Christianson, David Baker
Published 2021-06-01

Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial

by David Gunn, Ron Fried, Rabia Lalani, Amanda Farrin, Ivana Holloway, Tom Morris, Catherine Olivier, Rachael Kearns, Maura Corsetti, Mark Scott, Adam Farmer, Anton Emmanuel, Peter Whorwell, Yan Yiannakou, David Sanders, John Mclaughlin, Kapil Kapur, Maria Eugenicos, Ayesha Akbar, Nigel Trudgill, Lesley Houghton, Phil G. Dinning, Alexander C. Ford, Qasim Aziz, Robin Spiller
Published 2019-08-01